Maxcyte (MXCT) Other Non-Current Assets (2020 - 2026)

Maxcyte's (MXCT) quarterly Other Non-Current Assets came in at $2.6 million in Q1 2026, up 36.37% year-on-year from $1.9 million in Q1 2025, and up 5.63% on a QoQ basis from $2.5 million in Q4 2025.

Maxcyte (MXCT) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Maxcyte (MXCT) has 7 years of Other Non-Current Assets data on file, last reported at $2.6 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 36.37% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 36.37% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 61.03% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $2.6 million, up from $2.5 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for MXCT reached as high as $2.8 million in Q2 2025 and fell as low as $295000.0 in Q1 2024.
  • Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
  • Across the five-year window, Other Non-Current Assets plunged 62.15% in 2023 and surged 547.8% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $809000.0 in 2022, then slumped by 52.04% to $388000.0 in 2023, then jumped by 294.85% to $1.5 million in 2024, then jumped by 61.03% to $2.5 million in 2025, then increased by 5.63% to $2.6 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.6 million in Q1 2026, $2.5 million in Q4 2025, and $2.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 3.17 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 2.05 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 738.90 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 285.90 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.25 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 164.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 828.89 Mn
10 Maxcyte 110.62 Mn 110.62 Mn 8.08 Mn 2.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.61 Mn
Dec 31, 2025 2.47 Mn
Sep 30, 2025 2.58 Mn
Jun 30, 2025 2.80 Mn
Mar 31, 2025 1.91 Mn
Dec 31, 2024 1.53 Mn
Sep 30, 2024 1.05 Mn
Jun 30, 2024 640,000.00
Mar 31, 2024 295,000.00
Dec 31, 2023 388,000.00
Sep 30, 2023 619,400.00
Jun 30, 2023 597,300.00
Mar 31, 2023 399,300.00
Dec 31, 2022 809,000.00
Sep 30, 2022 1.19 Mn
Jun 30, 2022 920,500.00
Mar 31, 2022 1.05 Mn
Dec 31, 2021 316,700.00
Sep 30, 2021 318,100.00
Jun 30, 2021 1.70 Mn